Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme

Saadettin KilickapDepartment of Medical Oncology, Cumhuriyet University Faculty of Medicine, Sivas, TurkeyCorrespondence[email protected]

Ibrahim OztoprakDepartment of Radiology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey

Birsen YucelDepartment of Radiation Oncology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey

Click to increase image sizeClick to decrease image size

Declaration of interest: The authors declare that they have no competing interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme

Information for

Open access

Opportunities

Help and information

Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature